Istaroxime

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameIstaroxime
Drug Alias Nameistaroxima伊司他肟istaroximumistaroximeST-2744 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/potassium-transporting ATPase inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 2 activators
TargetsSodium/potassium-transporting ATPaseSarcoplasmic/endoplasmic reticulum calcium ATPase 2
Therapy Area/IndicationsAcutely decompensated congestive heart failureShock, CardiogenicHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandItaly +[6] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPending
Originator CompaniesSigma-Tau Spa
China Registration ClassN/A

Develop Information

Active CompaniesSeismic Pharmaceuticals Operations LLCSeismic Pharmaceutical Holdings LlcLee'S Pharmaceutical (Hk) Ltd +[5] 
Inactive CompaniesLee'S Pharmaceutical LtdZhaoke Pharmaceutical (Hefei) Co LtdCvie Therapeutics Co Ltd +[7] 
Active IndicationsShock, Cardiogenic
Inactive IndicationsAcutely decompensated congestive heart failureHeart Failure

Other Information

ATC CodeN/A
Related LinksWikipedia